Merck Total Liabilities 2010-2024 | MKKGY

Merck total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Merck total liabilities for the quarter ending June 30, 2024 were $22.894B, a 4.61% decline year-over-year.
  • Merck total liabilities for 2023 were $23.53B, a 0.83% decline from 2022.
  • Merck total liabilities for 2022 were $23.728B, a 16.25% decline from 2021.
  • Merck total liabilities for 2021 were $28.332B, a 0.09% increase from 2020.
Merck Annual Total Liabilities
(Millions of US $)
2023 $23,530
2022 $23,728
2021 $28,332
2020 $28,305
2019 $29,006
2018 $23,213
2017 $24,362
2016 $26,781
2015 $27,911
2014 $18,888
2013 $12,950
2012 $14,441
2011 $16,196
2010 $
2009 $
Merck Quarterly Total Liabilities
(Millions of US $)
2024-06-30 $22,894
2024-03-31 $23,267
2023-12-31 $23,530
2023-09-30 $23,523
2023-06-30 $24,000
2023-03-31 $24,052
2022-12-31 $23,728
2022-09-30 $22,759
2022-06-30 $24,146
2022-03-31 $26,086
2021-12-31 $28,332
2021-09-30 $27,307
2021-06-30 $28,657
2021-03-31 $30,029
2020-12-31 $28,305
2020-09-30 $29,500
2020-06-30 $28,404
2020-03-31 $28,841
2019-12-31 $29,006
2019-09-30 $26,560
2019-06-30 $24,721
2019-03-31 $23,898
2018-12-31 $23,213
2018-09-30 $23,711
2018-06-30 $24,966
2018-03-31 $25,900
2017-12-31 $24,362
2017-09-30 $25,902
2017-06-30 $25,308
2017-03-31 $25,438
2016-12-31 $26,781
2016-09-30 $26,505
2016-06-30 $27,302
2016-03-31 $27,149
2015-12-31 $27,911
2015-09-30 $20,298
2015-06-30 $17,589
2015-03-31 $19,118
2014-12-31 $18,888
2014-09-30 $14,512
2014-06-30 $14,077
2014-03-31 $13,384
2013-12-31 $12,950
2013-09-30 $13,969
2013-06-30 $14,698
2013-03-31 $15,110
2012-12-31 $14,441
2012-09-30 $14,645
2012-06-30 $14,601
2012-03-31
2011-12-31 $16,196
2011-09-30
2011-06-30 $16,602
2011-03-31
2010-12-31
2010-09-30 $16,096
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.076B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.098B 30.44
Takeda Pharmaceutical (TAK) Japan $43.496B 9.05
Astellas Pharma (ALPMY) Japan $19.237B 17.72
Sandoz Group AG (SDZNY) Switzerland $18.813B 0.00
United Therapeutics (UTHR) United States $16.715B 16.44
Summit Therapeutics (SMMT) United States $12.979B 0.00
Neurocrine Biosciences (NBIX) United States $12.933B 34.25
Shionogi (SGIOY) Japan $12.199B 12.22
Catalent (CTLT) United States $11.225B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.946B 0.00
Orion OYJ (ORINY) Finland $6.605B 18.57
Corcept Therapeutics (CORT) United States $6.376B 48.29
Ionis Pharmaceuticals (IONS) United States $5.866B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.296B 0.00
PTC Therapeutics (PTCT) United States $3.845B 0.00
Dyne Therapeutics (DYN) United States $2.996B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.730B 16.32
Catalyst Pharmaceuticals (CPRX) United States $2.619B 11.87
Centessa Pharmaceuticals (CNTA) United Kingdom $2.262B 0.00
Soleno Therapeutics (SLNO) United States $2.185B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.044B 0.00
Xencor (XNCR) United States $1.834B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.688B 0.00
Evotec AG (EVO) Germany $1.623B 0.00
Guardian Pharmacy Services (GRDN) United States $1.568B 0.00
Indivior (INDV) United States $1.566B 6.38
BioCryst Pharmaceuticals (BCRX) United States $1.518B 0.00
Ocular Therapeutix (OCUL) United States $1.490B 0.00
ARS Pharmaceuticals (SPRY) United States $1.401B 0.00
Harrow (HROW) United States $1.356B 0.00
Ardelyx (ARDX) United States $1.322B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.249B 0.00
Enliven Therapeutics (ELVN) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.004B 5.48
Avadel Pharmaceuticals (AVDL) Ireland $0.960B 0.00
Bioventus (BVS) United States $0.896B 28.31
Cronos Group (CRON) Canada $0.772B 0.00
USANA Health Sciences (USNA) United States $0.736B 13.64
Relay Therapeutics (RLAY) United States $0.735B 0.00
Oruka Therapeutics (ORKA) United States $0.734B 0.00
Esperion Therapeutics (ESPR) United States $0.721B 0.00
Altimmune (ALT) United States $0.701B 0.00
Tourmaline Bio (TRML) United States $0.656B 0.00
Elite Pharmaceuticals (ELTP) United States $0.635B 0.00
Savara (SVRA) United States $0.589B 0.00
ProKidney (PROK) United States $0.586B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.568B 0.00
Verve Therapeutics (VERV) United States $0.561B 0.00
OmniAb (OABI) United States $0.541B 0.00
Xeris Biopharma Holdings (XERS) United States $0.532B 0.00
Organogenesis (ORGO) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.478B 5.58
Theravance Biopharma (TBPH) Cayman Islands $0.472B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.467B 189.21
Akebia Therapeutics (AKBA) United States $0.443B 0.00
KalVista Pharmaceuticals (KALV) United States $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.393B 0.00
Larimar Therapeutics (LRMR) United States $0.388B 0.00
Korro Bio (KRRO) United States $0.362B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.361B 0.00
Sage Therapeutics (SAGE) United States $0.343B 0.00
Avita Medical (RCEL) United States $0.337B 0.00
4D Molecular Therapeutics (FDMT) United States $0.330B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 17.67
Aldeyra Therapeutics (ALDX) United States $0.295B 0.00
Lyell Immunopharma (LYEL) United States $0.275B 0.00
Aclaris Therapeutics (ACRS) United States $0.269B 0.00
Heron Therapeutics (HRTX) United States $0.249B 0.00
Silence Therapeutics (SLN) United Kingdom $0.248B 0.00
Lexeo Therapeutics (LXEO) United States $0.223B 0.00
Acrivon Therapeutics (ACRV) United States $0.210B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.195B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Nektar Therapeutics (NKTR) United States $0.188B 0.00
Inhibikase Therapeutics (IKT) United States $0.184B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.181B 0.00
Achieve Life Sciences (ACHV) Canada $0.156B 0.00
Telomir Pharmaceuticals (TELO) United States $0.153B 0.00
Galectin Therapeutics (GALT) United States $0.148B 0.00
Cassava Sciences (SAVA) United States $0.142B 0.00
Nanobiotix S.A (NBTX) France $0.136B 0.00
CytoDyn (CYDY) United States $0.134B 0.00
VAXART, INC (VXRT) United States $0.130B 0.00
Century Therapeutics (IPSC) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Journey Medical (DERM) United States $0.117B 0.00
Context Therapeutics (CNTX) United States $0.113B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Regulus Therapeutics (RGLS) United States $0.105B 0.00
Fractyl Health (GUTS) United States $0.105B 0.00
Avalo Therapeutics (AVTX) United States $0.104B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.100B 0.00
Assertio Holdings (ASRT) United States $0.092B 24.05
Arch Biopartners (ACHFF) Canada $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
OptiNose (OPTN) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.077B 0.00
ElectroCore (ECOR) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Protara Therapeutics (TARA) United States $0.073B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Mural Oncology (MURA) Ireland $0.068B 0.00
Iterum Therapeutics (ITRM) Ireland $0.066B 0.00
Scienture Holdings (SCNX) United States $0.064B 0.00
AlloVir (ALVR) United States $0.061B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
BioVie (BIVI) United States $0.049B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Nutriband (NTRB) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
FibroGen (FGEN) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.038B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Carisma Therapeutics (CARM) United States $0.034B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.033B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
CERo Therapeutics Holdings (CERO) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
BioLineRx (BLRX) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Talphera (TLPH) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.04
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.43